New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
08:10 EDTOCLSOculus receives patent for Microcyn Technology
Oculus Innovative Sciences, announced the issuance of new U.S. patent for the use of Microcyn Technology in the treatment of skin ulcers. In this application, Microcyn Technology can be delivered to skin ulcers via washing, irrigation and soaking or through application of a wound dressing saturated in the Microcyn Technology.
News For OCLS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
08:13 EDTOCLSOculus receives CE Mark for Microcyn-based atopic dermatitis Hydrogel
Oculus Innovative Sciences announced the issuance of a new CE Mark in Europe for Microcyn-based Pediacyn Hydrogel. Pediacyn Hydrogel is indicated for the care of lesions associated with atopic dermatitis by assisting with moistening while forming a protective barrier against physical, chemical and microbial invasion of the atopic dermatitis lesions.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use